These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12648224)

  • 1. Suppression of the immune response against exogenous desmoglein 3 in desmoglein 3 knockout mice: an implication for gene therapy.
    Ohyama M; Ota T; Aoki M; Tsunoda K; Harada R; Koyasu S; Nishikawa T; Amagai M
    J Invest Dermatol; 2003 Apr; 120(4):610-5. PubMed ID: 12648224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerance induction by the blockade of CD40/CD154 interaction in pemphigus vulgaris mouse model.
    Aoki-Ota M; Kinoshita M; Ota T; Tsunoda K; Iwasaki T; Tanaka S; Koyasu S; Nishikawa T; Amagai M
    J Invest Dermatol; 2006 Jan; 126(1):105-13. PubMed ID: 16417225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mouse model of pemphigus vulgaris by adoptive transfer of naive splenocytes from desmoglein 3 knockout mice.
    Aoki-Ota M; Tsunoda K; Ota T; Iwasaki T; Koyasu S; Amagai M; Nishikawa T
    Br J Dermatol; 2004 Aug; 151(2):346-54. PubMed ID: 15327541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transient anti-CD40L co-stimulation blockade prevents immune responses against human bullous pemphigoid antigen 2: implications for gene therapy.
    Lanschuetzer CM; Olasz EB; Lazarova Z; Yancey KB
    J Invest Dermatol; 2009 May; 129(5):1203-7. PubMed ID: 19037236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational epitope mapping of antibodies against desmoglein 3 in experimental murine pemphigus vulgaris.
    Anzai H; Fujii Y; Nishifuji K; Aoki-Ota M; Ota T; Amagai M; Nishikawa T
    J Dermatol Sci; 2004 Aug; 35(2):133-42. PubMed ID: 15265525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus.
    Amagai M; Tsunoda K; Suzuki H; Nishifuji K; Koyasu S; Nishikawa T
    J Clin Invest; 2000 Mar; 105(5):625-31. PubMed ID: 10712434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of CD40/CD40 ligand interactions prevents induction of factor VIII inhibitors in hemophilic mice but does not induce lasting immune tolerance.
    Reipert BM; Sasgary M; Ahmad RU; Auer W; Turecek PL; Schwarz HP
    Thromb Haemost; 2001 Dec; 86(6):1345-52. PubMed ID: 11776297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic IgG antibodies against desmoglein 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cells.
    Eming R; Hennerici T; Bäcklund J; Feliciani C; Visconti KC; Willenborg S; Wohde J; Holmdahl R; Sønderstrup G; Hertl M
    J Immunol; 2014 Nov; 193(9):4391-9. PubMed ID: 25252957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aire-dependent thymic expression of desmoglein 3, the autoantigen in pemphigus vulgaris, and its role in T-cell tolerance.
    Wada N; Nishifuji K; Yamada T; Kudoh J; Shimizu N; Matsumoto M; Peltonen L; Nagafuchi S; Amagai M
    J Invest Dermatol; 2011 Feb; 131(2):410-7. PubMed ID: 21048786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris.
    Mahoney MG; Wang Z; Rothenberger K; Koch PJ; Amagai M; Stanley JR
    J Clin Invest; 1999 Feb; 103(4):461-8. PubMed ID: 10021453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IgG binds to desmoglein 3 in desmosomes and causes a desmosomal split without keratin retraction in a pemphigus mouse model.
    Shimizu A; Ishiko A; Ota T; Tsunoda K; Amagai M; Nishikawa T
    J Invest Dermatol; 2004 May; 122(5):1145-53. PubMed ID: 15140217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic pathogenic effects of combined mouse monoclonal anti-desmoglein 3 IgG antibodies on pemphigus vulgaris blister formation.
    Kawasaki H; Tsunoda K; Hata T; Ishii K; Yamada T; Amagai M
    J Invest Dermatol; 2006 Dec; 126(12):2621-30. PubMed ID: 16841036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of desmoglein 1 compensates for genetic loss of desmoglein 3 in keratinocyte adhesion.
    Hanakawa Y; Matsuyoshi N; Stanley JR
    J Invest Dermatol; 2002 Jul; 119(1):27-31. PubMed ID: 12164920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No activation of urokinase plasminogen activator by anti-desmoglein 3 monoclonal IgG antibodies in cultured human keratinocytes.
    Yamamoto Y; Aoyama Y; Shu E; Tsunoda K; Amagai M; Kitajima Y
    J Dermatol Sci; 2007 Aug; 47(2):119-25. PubMed ID: 17532189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructural changes in mice actively producing antibodies to desmoglein 3 parallel those in patients with pemphigus vulgaris.
    Shimizu A; Ishiko A; Ota T; Tsunoda K; Koyasu S; Amagai M; Nishikawa T
    Arch Dermatol Res; 2002 Oct; 294(7):318-23. PubMed ID: 12373337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenic human monoclonal antibody against desmoglein 3.
    Yeh SW; Cavacini LA; Bhol KC; Lin MS; Kumar M; Duval M; Posner MR; Ahmed AR
    Clin Immunol; 2006 Jul; 120(1):68-75. PubMed ID: 16635589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confirmation of a disease model of pemphigus vulgaris: characterization and correlation between disease parameters in 90 mice.
    Holm TL; Markholst H
    Exp Dermatol; 2010 Aug; 19(8):e158-65. PubMed ID: 20201956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraperitoneal injection of pemphigus vulgaris-IgG into mouse depletes epidermal keratinocytes of desmoglein 3 associated with generation of acantholysis.
    Shu E; Yamamoto Y; Aoyama Y; Kitajima Y
    Arch Dermatol Res; 2007 Jun; 299(3):165-7. PubMed ID: 17431647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-independent development of Foxp3+ regulatory T cells suppressing autoantibody production in experimental pemphigus vulgaris.
    Yokoyama T; Matsuda S; Takae Y; Wada N; Nishikawa T; Amagai M; Koyasu S
    Int Immunol; 2011 Jun; 23(6):365-73. PubMed ID: 21525154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noncollagenous 16A domain of type XVII collagen-reactive CD4+ T cells play a pivotal role in the development of active disease in experimental bullous pemphigoid model.
    Ujiie H; Shibaki A; Nishie W; Shinkuma S; Moriuchi R; Qiao H; Shimizu H
    Clin Immunol; 2012 Feb; 142(2):167-75. PubMed ID: 22044750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.